LEADER 02416oas  2200865 a 450 
001 9910146961903321
005 20260203110342.0
011   $a1557-8127
035   $a(DE-599)ZDB2099740-1
035   $a(OCoLC)52126130
035   $a(CONSER)  2005214262
035   $a(CKB)111035998867022
035   $a(DE-599)2099740-1
035   $a(EXLCZ)99111035998867022
100   $a20030424a20029999  sy         a
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAssay and drug development technologies
210   $a[Larchmont, NY] $cMary Ann Liebert$d2002-
300   $aRefereed/Peer-reviewed
311 08$a1540-658X 
531 0 $aAssay drug dev. technol.
606   $aDrug development$vPeriodicals
606   $aBiological Assay$xmethods
606   $aDrug Evaluation, Preclinical$xinstrumentation
606   $aDrug Evaluation, Preclinical$xmethods
606   $aTechnology, Pharmaceutical$xinstrumentation
606   $aTechnology, Pharmaceutical$xmethods
606   $aBiological Assay$xinstrumentation
606   $aMe?dicaments$xDe?veloppement$vPe?riodiques
606   $aDrug development$2fast$3(OCoLC)fst00898670
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aDrug development
615  2$aBiological Assay$xmethods.
615  2$aDrug Evaluation, Preclinical$xinstrumentation.
615  2$aDrug Evaluation, Preclinical$xmethods.
615  2$aTechnology, Pharmaceutical$xinstrumentation.
615  2$aTechnology, Pharmaceutical$xmethods.
615  2$aBiological Assay$xinstrumentation.
615  6$aMe?dicaments$xDe?veloppement
615  7$aDrug development.
676   $a615
801  0$bF#A
801  1$bF#A
801  2$bOCLCQ
801  2$bNSD
801  2$bMYG
801  2$bLGG
801  2$bOCLCQ
801  2$bDLC
801  2$bOCLCQ
801  2$bOCLCF
801  2$bOCLCQ
801  2$bEUW
801  2$bOCLCQ
801  2$bAU@
801  2$bOCLCO
801  2$bUKMGB
801  2$bOCLCA
801  2$bSFB
801  2$bUEJ
801  2$bOCLCQ
801  2$bIOY
801  2$bOCLCL
801  2$bADU
801  2$bLVT
801  2$bOCLCQ
906   $aJOURNAL
912   $a9910146961903321
996   $aAssay and drug development technologies$92100831
997   $aUNINA